Annual report pursuant to Section 13 and 15(d)

Document And Entity Information

v3.22.2
Document And Entity Information - USD ($)
 12 Months Ended
Dec. 31, 2021
Jul. 14, 2021
Jun. 30, 2020
Document Information Line Items      
Entity Registrant Name Emmaus Life Sciences, Inc.    
Document Type 10-K/A    
Current Fiscal Year End Date --12-31    
Entity Common Stock, Shares Outstanding   49,311,864  
Entity Public Float     $ 58,283,977
Amendment Flag true    
Amendment Description Emmaus Life Sciences, Inc. is filing this Form 10-K/A to amend its Annual Report on Form 10-K for the fiscal year ended December 31, 2021, filed with the Securities and Exchange Commission (the “SEC”) on March 31, 2022, for purposes of adding certain exhibits inadvertently omitted therefrom.    
Entity Central Index Key 0000822370    
Entity Current Reporting Status No    
Entity Voluntary Filers No    
Entity Filer Category Non-accelerated Filer    
Entity Well-known Seasoned Issuer No    
Document Period End Date Dec. 31, 2021    
Document Fiscal Year Focus 2021    
Document Fiscal Period Focus FY    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
ICFR Auditor Attestation Flag false    
Document Annual Report true    
Document Transition Report false    
Entity File Number 001-35527    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 87-0419387    
Entity Address, Address Line One 21250 Hawthorne Boulevard    
Entity Address, Address Line Two Suite 800    
Entity Address, City or Town Torrance    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 90503    
City Area Code 310    
Local Phone Number 214-0065    
Title of 12(b) Security Common stock, $0.001 par value    
Entity Interactive Data Current No    
Auditor Name BAKER TILLY US, LLP    
Auditor Location San Diego, California    
Auditor Firm ID 23